HealthEquity, Inc.
HQY
$91.61
-$0.89-0.96%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.20% | 15.45% | 19.21% | 20.03% | 18.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.20% | 15.45% | 19.21% | 20.03% | 18.47% |
| Cost of Revenue | 4.47% | 10.51% | 12.36% | 12.09% | 6.17% |
| Gross Profit | 16.30% | 18.11% | 23.16% | 24.83% | 26.22% |
| SG&A Expenses | -1.81% | 1.40% | 6.83% | 21.90% | 17.96% |
| Depreciation & Amortization | -0.08% | 6.21% | 19.12% | 20.61% | 16.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.27% | 8.19% | 11.37% | 14.40% | 9.81% |
| Operating Income | 49.93% | 52.70% | 67.59% | 58.33% | 89.66% |
| Income Before Tax | 112.88% | 41.73% | 56.46% | 54.63% | 155.43% |
| Income Tax Expenses | 186.40% | 57.45% | 79.09% | 0.02% | 17.89% |
| Earnings from Continuing Operations | 98.37% | 38.01% | 51.44% | 73.58% | 231.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 98.37% | 38.01% | 51.44% | 73.58% | 231.86% |
| EBIT | 49.93% | 52.70% | 67.59% | 58.33% | 89.66% |
| EBITDA | 25.96% | 27.65% | 36.03% | 29.91% | 38.30% |
| EPS Basic | 98.79% | 37.75% | 50.09% | 71.47% | 227.84% |
| Normalized Basic EPS | 61.92% | 60.29% | 78.25% | 80.52% | 162.72% |
| EPS Diluted | 100.30% | 37.74% | 49.23% | 71.31% | 224.58% |
| Normalized Diluted EPS | 62.22% | 60.40% | 77.95% | 79.79% | 161.27% |
| Average Basic Shares Outstanding | -0.26% | 0.52% | 1.16% | 1.53% | 1.70% |
| Average Diluted Shares Outstanding | -0.37% | 0.54% | 1.46% | 2.08% | 2.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |